Enquyst Technologies is on a quest to engineer next-generation biomanufacturing technology solutions to give the growing diversity of life changing and curative treatments a viable path to the clinic with affordable costs. The unprecedentedly high purity resulting from Enquyst’s patented, core IPP technology is expected to deliver a scalable solution for the purification of AAV and lentiviral vector-based gene therapies, enabling development and rapid growth of these markets.
Company Details
- Employees
- 8
- Founded
- 2017
- Address
- 600 Suffolk St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.enquyst.com
- Keywords
- Continuous Manufacturing, Vector Based Gene Therapy, Monoclonal Antibody, Viral Vector, Purification, Peptides, Plasmid, Bispecific Antibody, Biotech, mRNA, Oligonucleotides, Chromatography Free, mAbs, AAV, LV.
- HQ
- Lowell, Massachusetts
Enquyst Technologies Inc Questions
Enquyst Technologies Inc's website is http://www.enquyst.com
Enquyst Technologies Inc's LinkedIn profile is https://www.linkedin.com/company/enquyst-technologies-inc
Enquyst Technologies Inc has
8 employees.
View email and phone details for 8
employees at Enquyst Technologies Inc.
Enquyst Technologies Inc's industry is
Biotechnology Research
Enquyst Technologies Inc's top competitors are
Cellicure, Inc.,
Polpharma Biologics,
Matterworks,
Endeavor Biomedicines,
Huma,
Senior Helpers Of Westford,
Cubicpv Inc.,
Ansella Therapeutics,
Eckuity Capital,
Nascent Materials.
Enquyst Technologies Inc's categories are Biotechnology Research
Enquyst Technologies Inc's founding year is 2017
